ALLERGAN INC 4
4 · ALLERGAN INC · Filed Mar 19, 2015
Insider Transaction Report
Form 4
ALLERGAN INCAGN
Proctor Timothy D
Director
Transactions
- Disposition to Issuer
Common Stock
2015-03-17−6,796.96→ 0 total - Exercise/Conversion
Phantom Stock Units
2015-03-17−1,189.96→ 0 totalFrom: 2015-03-17Exp: 2015-03-17→ Common Stock (1,189.96 underlying) - Exercise/Conversion
Common Stock
2015-03-17+1,189.96→ 6,796.96 total
Footnotes (3)
- [F1]Each phantom stock unit ("PSU") was the economic equivalent of one share of the Issuer's common stock. Each PSU settled in full on the Effective date (as define below) in connection with the reporting person's termination of service. The amount shown includes shares acquired pursuant to dividend rights attached to each PSU.
- [F2]Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51per share on the Effective Date.
- [F3]The number of shares reported on this line item includes shares acquired pursuant to dividend rights attached to restricted stock units that were previously granted and reported as Table 1, Non-Derivative Securities.